Evolutionary Therapy for Rhabdomyosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE2
Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- Status
- RECRUITING
- Phase
- PHASE2
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
- Status
- RECRUITING
- Phase
- PHASE1
"Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for CD19-positive ALL
- Status
- UNKNOWN
- Phase
- PHASE1
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Status
- SUSPENDED
- Phase
- PHASE1
Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation
- Status
- COMPLETED
- Phase
- PHASE3
CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2